analysis of the pharmaceutical industry in ethiopia, adapted sales brochure
DESCRIPTION
TRANSCRIPT
Market Engineering Research
Analysis of The Pharmaceutical Industry in Ethiopia
Identifying and Evaluating Market Trends for Specific Therapeutic
Agents
Healthcare (HC)
Research Service Code: M863-52
Completion date: August 2012
M863-52 2
Contents
Section Slide Numbers
Summary of Study 3
Research Aims and Objectives 4
Scope of Research 5
Research and Respondent Scope 6
Methodology Followed 7
Research Deliverables 8
Benefits of Research 10
Frost and Sullivan Company Information and Contacts 11
Contents
M863-52 3
Ethiopian
Pharmaceutical
Industry
Summary of Study
• A key finding of this research identifies the Pharmaceutical industry in
Ethiopia to be worth $945.8 million in 2017.
• In addition to the large pharmaceutical market opportunity, the industry is
expected to witness a CAGR of 14.8 per cent over the forecast period
(2012-2017).
• The Anti-infectives, Cardiovascular and Diabetes Therapeutic segments
present the largest opportunity for growth.
• Generic pharmaceutical products dominate the market as they favour
highly price sensitive consumers.
`
EthiopiaMarket Value (2011)
$422.2 M
This research service provides a strategic analysis of the
Ethiopian Pharmaceutical Industry over the period 2009 to
2017. The market size and growth of the total pharmaceutical
industry, including six main therapeutic segments that
characterize the prescription drug market are presented. A
brief competitive overview is provided for the total market.
Insight into the market dynamics, particularly the drivers and
restraints as well as the opportunities of the pharmaceutical
market, is provided.
M863-52 4
Research Aims and Objectives—Key Questions
This Study Will Answer
How is the health care in Ethiopia structured? What regulations govern the pharmaceutical industry
and how will these regulations impact the market in the future?
What is the size and growth potential of various therapeutic segments in the pharmaceutical industry?
What opportunities exists for each of these segments?
Who are the existing competitors in the Ethiopian pharmaceutical industry and how is their marketing
strategy structured to meet basic customer needs?
Who are the various competitors of the various therapeutic segments in the industry? How is the
market divided amongst these competitors?
3
4
5
1
The aim of this research service is to characterise the opportunities that exists for specific therapeutic
classes within the Ethiopian Pharmaceutical Industry
What factors contribute to the key growth opportunities in each therapeutic segment and what
strategic recommendations can assist participants to capitalize on those opportunities?6
What is the size and growth potential of the pharmaceutical industry in Ethiopia? What are the drivers,
restraints, and challenges within the industry?2
M863-52 5
Scope of Research
Product Scope
The research service will focus on specific pharmaceutical therapeutic
segments namely; Anti-infectives, Cardiovascular, Diabetes, Central
nervous System, Respiratory and Oncology
Geographic Scope
This research service focuses on the Ethiopian Pharmaceutical market.
`
Total Pharmaceutical Industry
Anti-Infectives
Segment
Cardiovascular
Segment
Diabetes
Segment
Respiratory
Segment
Central Nervous
System Segment
Oncology
Segment
Ethiopia
Generic products
Branded products
M863-52 6
Methodology & Respondent Scope
For Market Engineering research, Frost & Sullivan utilises tried and tested
marketing techniques to provide structure to the research and an easy format
to compare results across different countries, markets and over time.
This project was carried out using primary research (telephone or face-to-face
interviews) and secondary (published and online material) as the principle
methods of data gathering. The focus of the interviews for this project were
primarily the respondent types outlined in the figure below.
Organisation Type Target Designations Type of Information
Public and Private Hospitals and
Clinics Procurement Officers, Directors of
Pharmacy
Expenditure, Key Products in Demand,
Key Products in Use, Challenges,
Procurement Process, Key Suppliers
Regulatory bodies, Associations
and SocietiesAdministration Officers, Directors
Regulatory Process, Industry Overview,
Industry Structure, Key Participants,
Expenditure, Government Projects
Pharmaceutical Manufacturers,
Suppliers & Distributors
CEOs, MDs, Marketing Managers,
General Managers, Sales Managers
Industry Trends, Technology Trends,
Challenges, Drivers, Restraints, Revenues,
Growth Opportunities, Competitive
Dynamics
M863-52 7
This Research Service provides a strategic overviewof the Ethiopian Pharmaceutical Industry and followsthe principle of Frost & Sullivan's Market Engineeringresearch methodology. This measurement-basedmethodology focuses on market measurement,analysis, forecasting, strategy development andmonitoring.
Data retrieved from the secondary and primaryresearch regarding the Ethiopian PharmaceuticalIndustry was compiled, tested and engineered toprovide a market structure and market forecasts
This study is based on thorough secondary and primary research principles. Extensiveinterviews were conducted with key stakeholders. Market participants in the supply side ofpharmaceutical products also provided key market information allowing for a top-downanalysis of this market in Ethiopia.
Frost & Sullivan’s
Market Engineering Research Methodology
Methodology Followed
M863-52 8
Research Deliverables 1/2
Market Engineering
Measurements
Competitive Assessment
Market Drivers and Restraints
Market Overview
M863-52 9
Research Deliverables 2/2
Pharmaceutical Procurement
Healthcare Overview
RegulatoryOverview
Forecast and Trends
M863-52 10
Provides a competitive analysis and recommendations
Provides insights into industry dynamics
Research Benefits
Overview of regulatory systems and supply of
pharmaceutical product in the country
Key market drivers and restraints for the
Pharmaceutical Industry
2
3
4
5
7
6
8
1
Comprehensive revenue forecasts by total
Market and Therapeutic Segments
Analysis of the Pharmaceutical Industry in
Ethiopia
Analysis of the key market players within
each country
Identifies growth opportunities
within the Market and Therapeutic Segments
Benefits of Research
M863-52 11
Phil Howarth
Operations Director
Frost & Sullivan Africa
+27 21 680 3269
Danielle Kruger
Account Manager
Frost & Sullivan
+27 21 680 3262
+27 72 878 0698
Kate Howarth
Sales Manager
Frost & Sullivan Africa
+27 21 680 3261
Mani James
Programme Manager
Chemicals, Materials and Food
+27 21 680 3208
Frost & Sullivan Contacts